MX9604109A - Agente para disminuir la tension ocular. - Google Patents
Agente para disminuir la tension ocular.Info
- Publication number
- MX9604109A MX9604109A MX9604109A MX9604109A MX9604109A MX 9604109 A MX9604109 A MX 9604109A MX 9604109 A MX9604109 A MX 9604109A MX 9604109 A MX9604109 A MX 9604109A MX 9604109 A MX9604109 A MX 9604109A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- formula
- alkenyl
- agent
- group
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 2
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000003889 eye drop Substances 0.000 abstract 1
- 229940012356 eye drops Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 150000003536 tetrazoles Chemical class 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4540494 | 1994-03-16 | ||
| PCT/JP1995/000444 WO1995024902A1 (en) | 1994-03-16 | 1995-03-16 | Ocular tension depressant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9604109A true MX9604109A (es) | 1997-09-30 |
Family
ID=12718322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9604109A MX9604109A (es) | 1994-03-16 | 1995-03-16 | Agente para disminuir la tension ocular. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5925664A (OSRAM) |
| EP (2) | EP0795326B1 (OSRAM) |
| KR (1) | KR100211446B1 (OSRAM) |
| CN (2) | CN1104898C (OSRAM) |
| AT (2) | ATE266402T1 (OSRAM) |
| AU (1) | AU684916B2 (OSRAM) |
| CZ (1) | CZ284395B6 (OSRAM) |
| DE (2) | DE69533045T2 (OSRAM) |
| DK (2) | DK0795326T3 (OSRAM) |
| ES (2) | ES2163501T3 (OSRAM) |
| FI (2) | FI114897B (OSRAM) |
| GR (1) | GR3036989T3 (OSRAM) |
| HK (1) | HK1000551A1 (OSRAM) |
| HU (1) | HUT74734A (OSRAM) |
| MX (1) | MX9604109A (OSRAM) |
| NO (1) | NO311068B1 (OSRAM) |
| NZ (1) | NZ282485A (OSRAM) |
| PT (2) | PT795326E (OSRAM) |
| RU (1) | RU2123847C1 (OSRAM) |
| WO (1) | WO1995024902A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA01012752A (es) | 1999-06-11 | 2002-07-02 | Sankyo Co | Composiciones reductoras de tension intraocular para administracion topica. |
| JP4000505B2 (ja) * | 1999-12-01 | 2007-10-31 | 第一三共株式会社 | 緑内障を治療するための併用剤 |
| GR20000100281A (el) * | 2000-08-17 | 2002-05-24 | Ιωαννης Ματσουκας | Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων |
| AU2002218527A1 (en) * | 2000-12-05 | 2002-06-18 | Sankyo Company Limited | Ocular tension-lowering compositions for topical administration |
| KR101087519B1 (ko) * | 2003-04-15 | 2011-11-28 | 상꾜 가부시키가이샤 | 안구 내 혈관 신생성 질환의 예방 또는 치료를 위한 의약 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2549049B1 (fr) * | 1983-07-13 | 1986-06-20 | Chauvin Blache Lab | Nouvelles amidines, leur procede de preparation et leur application therapeutique |
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US5138069A (en) * | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| JPS6323868A (ja) * | 1986-07-11 | 1988-02-01 | イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー | アンギオテンシン２受容体遮断性イミダゾ−ル |
| US4820843A (en) * | 1987-05-22 | 1989-04-11 | E. I. Du Pont De Nemours And Company | Tetrazole intermediates to antihypertensive compounds |
| CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
| US4916129A (en) * | 1989-01-19 | 1990-04-10 | E. I. Du Pont De Nemours And Company | Combination β-blocking/angiotensin II blocking antihypertensives |
| AU644802B2 (en) * | 1989-06-30 | 1993-12-23 | E.I. Du Pont De Nemours And Company | Substituted imidazoles |
| WO1991015206A1 (en) * | 1990-04-05 | 1991-10-17 | E.I. Du Pont De Nemours And Company | Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists |
| US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
| US5126342A (en) * | 1990-10-01 | 1992-06-30 | Merck & Co., Inc. | Imidazole angiotensin ii antagonists incorporating acidic functional groups |
| US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
| CA2061607C (en) * | 1991-02-21 | 1999-01-19 | Hiroaki Yanagisawa | 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
| DE4132631A1 (de) * | 1991-10-01 | 1993-04-08 | Bayer Ag | Imidazolyl-propensaeurederivate |
| US5219856A (en) * | 1992-04-06 | 1993-06-15 | E. I. Du Pont De Nemours And Company | Angiotensin-II receptor blocking, heterocycle substituted imidazoles |
| ES2155827T3 (es) * | 1992-06-02 | 2001-06-01 | Sankyo Co | 4-carboxiimidazoles como antagonistas de la angiotensina ii y su uso terapeutico. |
| US5310929A (en) * | 1992-08-06 | 1994-05-10 | E. I. Du Pont De Nemours And Company | Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists |
| NO304429B1 (no) * | 1992-12-17 | 1998-12-14 | Sankyo Co | Bifenylderivater, farmas°ytisk preparat og deres anvendelse for fremstilling av et medikament for behandling av hypertensjon og hjertesykdom |
| CZ154994A3 (en) * | 1993-07-02 | 1995-09-13 | Senju Pharma Co | Visual hypotensive agent |
| ES2243933T3 (es) * | 1994-02-08 | 2005-12-01 | Novartis Ag | Tratamiento de glaucoma normotensivo con antagonistas de angiotensina ii. |
-
1995
- 1995-03-16 ES ES95912428T patent/ES2163501T3/es not_active Expired - Lifetime
- 1995-03-16 PT PT95912428T patent/PT795326E/pt unknown
- 1995-03-16 PT PT01102527T patent/PT1110551E/pt unknown
- 1995-03-16 RU RU96121253A patent/RU2123847C1/ru active
- 1995-03-16 WO PCT/JP1995/000444 patent/WO1995024902A1/ja not_active Ceased
- 1995-03-16 HU HU9602534A patent/HUT74734A/hu unknown
- 1995-03-16 CN CN95193132A patent/CN1104898C/zh not_active Expired - Fee Related
- 1995-03-16 DK DK95912428T patent/DK0795326T3/da active
- 1995-03-16 AU AU19602/95A patent/AU684916B2/en not_active Ceased
- 1995-03-16 CZ CZ962694A patent/CZ284395B6/cs not_active IP Right Cessation
- 1995-03-16 DE DE69533045T patent/DE69533045T2/de not_active Expired - Fee Related
- 1995-03-16 DK DK01102527T patent/DK1110551T3/da active
- 1995-03-16 DE DE69522955T patent/DE69522955T2/de not_active Expired - Fee Related
- 1995-03-16 NZ NZ282485A patent/NZ282485A/en not_active IP Right Cessation
- 1995-03-16 MX MX9604109A patent/MX9604109A/es not_active IP Right Cessation
- 1995-03-16 KR KR1019960705082A patent/KR100211446B1/ko not_active Expired - Fee Related
- 1995-03-16 AT AT01102527T patent/ATE266402T1/de not_active IP Right Cessation
- 1995-03-16 AT AT95912428T patent/ATE206050T1/de not_active IP Right Cessation
- 1995-03-16 EP EP95912428A patent/EP0795326B1/en not_active Expired - Lifetime
- 1995-03-16 EP EP01102527A patent/EP1110551B1/en not_active Expired - Lifetime
- 1995-03-16 ES ES01102527T patent/ES2221872T3/es not_active Expired - Lifetime
-
1996
- 1996-09-13 NO NO19963854A patent/NO311068B1/no not_active IP Right Cessation
- 1996-09-16 US US08/725,197 patent/US5925664A/en not_active Expired - Fee Related
- 1996-09-16 FI FI963645A patent/FI114897B/fi active IP Right Grant
-
1997
- 1997-10-23 HK HK97102015A patent/HK1000551A1/en not_active IP Right Cessation
-
2001
- 2001-10-24 GR GR20010401862T patent/GR3036989T3/el not_active IP Right Cessation
-
2002
- 2002-05-11 CN CNB021199396A patent/CN1202819C/zh not_active Expired - Fee Related
-
2004
- 2004-09-24 FI FI20041236A patent/FI115197B/fi active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO304111B1 (no) | Heteroeddiksyrederivater, farmas°ytiske midler inneholdende dem samt deres anvendelse for fremstilling av farmas°ytiske preparater | |
| EE03194B1 (et) | Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod | |
| ATE152719T1 (de) | Chinolylbenzofuran derivate als leukotrien- antagonisten | |
| CO4920223A1 (es) | Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos | |
| ES2053509T3 (es) | Compuestos de acido 3-pirrolidiniltio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilico y procedimientos para su preparacion. | |
| DE69728544D1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
| BG101402A (en) | Apoliprotein-b synthesis inhibitors | |
| KR950031062A (ko) | 안압 강하용 점안제 | |
| MX9604109A (es) | Agente para disminuir la tension ocular. | |
| MY106314A (en) | New tetrazole derivatives, process for their preparation and their use | |
| CO4750814A1 (es) | Nuevos derivados de fenilamidina, su procedimiento para su preparacion y su utilizacion como medicamentos | |
| CO4130335A1 (es) | Nuevos productos farmaceuticos que son piranoquinolinas sus- tituidas con fenilos o heteroarilos | |
| GB1531946A (en) | Cyclopentane derivatives useful as perfuming agents | |
| ATE228520T1 (de) | Lactamverbindungen als inhibitoren der cholesterin-esterase | |
| ES8401928A1 (es) | Procedimiento de obtencion de composiciones oftalmologicas. | |
| AR001150A1 (es) | Nuevo procedimiento para preparar derivados 2,3-dihidrobenzofuranol | |
| DE59808546D1 (de) | Verwendung von fettsäureniedrigalkylestern in abbeizmitteln | |
| NO842534L (no) | Fremgangsmaate ved fremstilling av nye prostacyclinderivater | |
| KR950032158A (ko) | 신규의 티아진 또는 티오모폴린 유도체 | |
| CA2185524A1 (en) | Ocular tension depressant | |
| EP0627425A4 (OSRAM) | ||
| DE69303917D1 (de) | Färbemittel für keratinische Fasern, die 4-Monoindolyl 1,2-naphthochinone enthalten, 4-Monoindolyl 1,2-naphthochinone | |
| ES8404338A1 (es) | Procedimiento para la obtencion de oxazolidin-2-onas. | |
| ES2071713T3 (es) | N-heterociclometil-spiroheterociclos y los fungicidas que les contienen. | |
| CO4940508A1 (es) | 2,4-diaminopirimidina substituida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |